Clinical Trial to Slow the Progression of ADPKD
The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2005 by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
Recruitment status was Not yet recruiting
Recruitment status was Not yet recruiting
Sponsor:
Information provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier:
NCT00067977
First received: September 3, 2003
Last updated: November 2, 2005
Last verified: November 2005
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study will determine whether certain blood pressure medications will slow cyst growth or keep kidneys functioning longer in patients with autosomal dominant polycystic kidney disease (ADPKD). The study will take place at several sites in the United States. The start date of the study has not yet been determined.
| Condition | Intervention |
|---|---|
|
Kidney, Polycystic Kidney, Polycystic, Autosomal Dominant |
Drug: anti-hypertensive medications |
| Study Type: | Interventional |
| Study Design: | Primary Purpose: Treatment |
Resource links provided by NLM:
Genetics Home Reference related topics:
polycystic kidney disease
MedlinePlus related topics:
Blood Pressure Medicines
U.S. FDA Resources
Further study details as provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):
Eligibility| Ages Eligible for Study: | 15 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
- Previous diagnosis of autosomal dominant polycystic kidney disease by abdominal imaging
- Previous diagnosis of high blood pressure or current blood pressures above 130/80 mm Hg
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00067977
Locations
| United States, Colorado | |
| University of Colorado Health Sciences Center | Not yet recruiting |
| Denver, Colorado, United States, 80262 | |
| Contact: Lyn Tison 877-765-9297 | |
| United States, Georgia | |
| Emory University | Not yet recruiting |
| Atlanta, Georgia, United States | |
| Contact 404-370-7344 | |
| United States, Kansas | |
| Kansas University Medical Center | Not yet recruiting |
| Kansas City, Kansas, United States | |
| Contact 913-588-7609 | |
| United States, Massachusetts | |
| Tufts - New England Medical Center | Not yet recruiting |
| Boston, Massachusetts, United States | |
| Contact 617-636-8763 | |
| Beth Israel Deaconess Medical Center | Not yet recruiting |
| Boston, Massachusetts, United States | |
| United States, Minnesota | |
| Mayo Clinic | Not yet recruiting |
| Rochester, Minnesota, United States | |
| Contact 507-284-0944 | |
| United States, Ohio | |
| Cleveland Clinic Foundation | Not yet recruiting |
| Cleveland, Ohio, United States | |
| Contact 800-223-2273 ext 44680 | |
Sponsors and Collaborators
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00067977 History of Changes |
| Other Study ID Numbers: | ADPKD |
| Study First Received: | September 3, 2003 |
| Last Updated: | November 2, 2005 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):
|
PKD ADPKD polycystic kidney disease autosomal dominant polycystic kidney disease |
Additional relevant MeSH terms:
|
Polycystic Kidney Diseases Polycystic Kidney, Autosomal Dominant Kidney Diseases, Cystic Kidney Diseases Urologic Diseases |
Antihypertensive Agents Cardiovascular Agents Therapeutic Uses Pharmacologic Actions |
ClinicalTrials.gov processed this record on May 16, 2013